AU2001271544A1 - Oral compositions comprising host-response modulating agent - Google Patents
Oral compositions comprising host-response modulating agentInfo
- Publication number
- AU2001271544A1 AU2001271544A1 AU2001271544A AU7154401A AU2001271544A1 AU 2001271544 A1 AU2001271544 A1 AU 2001271544A1 AU 2001271544 A AU2001271544 A AU 2001271544A AU 7154401 A AU7154401 A AU 7154401A AU 2001271544 A1 AU2001271544 A1 AU 2001271544A1
- Authority
- AU
- Australia
- Prior art keywords
- host
- agents
- oral
- present
- oral cavity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Finger-Pressure Massage (AREA)
Abstract
The present invention relates to topical oral care compositions comprising in a pharmaceutically acceptable carrier a safe and effective amount of a host-response modulating agent including one or more of an anti-oxidant and modifier of cell redox status, anti-inflammatory agent, metalloproteinase inhibitor, vitamins and nutrients key to maintenance of a host response balance and inhibitor of activation of NF-kB in combination with one or a mixture of additional oral therapeutic actives selected from antimicrobial/antiplaque agents, biofilm inhibiting agents, antibiotics; analgesics and local anesthetic agents; dentinal desensitizing agents and odor masking agents. The present compositions are effective in treating and preventing bacteria-mediated diseases present in the oral cavity and in mediating host reaction to the presence of pathogenic bacteria in the oral cavity as well as the toxins and endotoxins, inflammatory cytokines and mediators released or prompted by these oral pathogens. By controlling bacteria-mediated diseases and conditions present in the oral cavity and modulating host reaction, spread into the bloodstream and other parts of the body of pathogenic bacteria and associated harmful substances is prevented or minimized.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60760200A | 2000-06-30 | 2000-06-30 | |
US09/607,602 | 2000-06-30 | ||
PCT/US2001/020515 WO2002002096A2 (en) | 2000-06-30 | 2001-06-28 | Oral compositions comprising host-response modulating agent |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001271544A1 true AU2001271544A1 (en) | 2002-01-14 |
Family
ID=24432968
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001271544A Abandoned AU2001271544A1 (en) | 2000-06-30 | 2001-06-28 | Oral compositions comprising host-response modulating agent |
Country Status (12)
Country | Link |
---|---|
US (1) | US8277782B2 (en) |
EP (1) | EP1294367B1 (en) |
JP (1) | JP4754155B2 (en) |
CN (1) | CN1536989A (en) |
AT (1) | ATE401065T1 (en) |
AU (1) | AU2001271544A1 (en) |
CA (1) | CA2415065C (en) |
DE (1) | DE60134854D1 (en) |
ES (1) | ES2309076T3 (en) |
MX (1) | MXPA03000043A (en) |
PE (1) | PE20020102A1 (en) |
WO (1) | WO2002002096A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115024355A (en) * | 2022-06-09 | 2022-09-09 | 宁波大学科学技术学院 | Preparation method of allicin-based fresh-keeping coating for chilled fresh meat by composite carrier coating |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8283135B2 (en) * | 2000-06-30 | 2012-10-09 | The Procter & Gamble Company | Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
US20040101494A1 (en) | 2002-11-26 | 2004-05-27 | Scott Douglas Craig | Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth |
EP1663126A1 (en) | 2003-09-09 | 2006-06-07 | DSM IP Assets B.V. | Orally effective, essentially water-free topical agent containing one or several oxidation-sensitive substances |
EP1691631A4 (en) | 2003-11-07 | 2012-09-05 | Us Smokeless Tobacco Co | Tobacco compositions |
US8627828B2 (en) | 2003-11-07 | 2014-01-14 | U.S. Smokeless Tobacco Company Llc | Tobacco compositions |
ZA200609927B (en) | 2004-05-28 | 2008-07-30 | Unigen Pharmaceuticals Inc | Diarylalkanes as potent inhibitors of binuclear enzymes |
US8168161B2 (en) * | 2004-12-22 | 2012-05-01 | Hill's Pet Nutrition, Inc. | Method to promote oral health in companion animals |
JP2006182662A (en) * | 2004-12-27 | 2006-07-13 | Lion Corp | Dentifrice composition |
WO2006071659A1 (en) * | 2004-12-29 | 2006-07-06 | Trustees Of Boston University | Delivery of h2 antagonists |
KR101081220B1 (en) | 2005-11-04 | 2011-11-07 | 더 프록터 앤드 갬블 캄파니 | Multi-function oral care device |
US20070140990A1 (en) * | 2005-12-21 | 2007-06-21 | Nataly Fetissova | Oral Compositions Comprising Propolis |
ES2605794T3 (en) | 2006-07-20 | 2017-03-16 | Izun Pharmaceuticals Corporation | Solid adhesive film, patch or formulation comprising Sambucus nigra, Centella asiatica and 1-alkylpyridinium salt for the treatment of mucous tissues |
US8858995B2 (en) | 2008-03-10 | 2014-10-14 | University Of Louisville Research Foundation, Inc. | Methods and compositions for controlled delivery of phytochemical agents |
AU2009223653B2 (en) * | 2008-03-10 | 2014-07-31 | University Of Louisville Research Foundation, Inc. | Methods and compositions for controlled delivery of phytochemical agents |
KR102107460B1 (en) | 2008-07-21 | 2020-05-08 | 유니젠, 인크. | Series of skin-whitening (lightening) compounds |
US9237988B2 (en) * | 2010-02-24 | 2016-01-19 | Bisco, Inc. | Benzalkonium chloride compositions for inhibiting the hydrolytic activity of endogenous matrix metalloproteinases in dental restorations |
AU2012231008B2 (en) | 2011-03-24 | 2017-05-11 | Unigen, Inc. | Compounds and methods for preparation of diarylpropanes |
US8731747B2 (en) | 2011-04-28 | 2014-05-20 | General Electric Company | Communication systems and method for a rail vehicle or other powered system |
US8798807B2 (en) | 2011-06-13 | 2014-08-05 | General Electric Company | Data distribution system and method for distributing data in a vehicle |
US8620552B2 (en) | 2011-06-13 | 2013-12-31 | General Electric Company | Data communication system and method for communicating data in a vehicle |
US8510026B2 (en) | 2011-06-13 | 2013-08-13 | General Electric Company | Data conversion system and method for converting data that is distributed in a vehicle |
CA2849910A1 (en) | 2011-09-30 | 2013-04-04 | Perio Sciences, Llc | Antioxidant compositions for treatment of inflammation or oxidative damage |
US20130274650A1 (en) * | 2012-04-17 | 2013-10-17 | Luitpold Pharmaceuticals, Inc. | Stabilized ketorolac compositions |
US20150210964A1 (en) | 2014-01-24 | 2015-07-30 | The Procter & Gamble Company | Consumer Product Compositions |
CN110024726B (en) * | 2019-04-03 | 2022-03-08 | 中国水产科学研究院长江水产研究所 | Application of natural product in activating activity of channel catfish nuclear receptors AHR1 and AHR2 |
WO2020210509A1 (en) * | 2019-04-10 | 2020-10-15 | Black Tulip Management, Inc. | Oral rinse compositions for reducing pathogens underlying tooth decay, periodontitis and oral malodor |
CA3136627C (en) * | 2019-04-10 | 2024-01-02 | Black Tulip Management, Inc. | Oral rinse compositions for reducing pathogens underlying and for treating periodontal disease and oral malodor in the canine |
CN112494483B (en) * | 2020-11-13 | 2022-09-02 | 兰州大学 | Application of dithiolethiones compound in antibacterial aspect |
Family Cites Families (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4599228A (en) | 1981-01-19 | 1986-07-08 | Vipont Laboratories, Inc. | Antimicrobial agent |
US5531982A (en) * | 1987-01-30 | 1996-07-02 | Colgate Palmolive Company | Antimicrobial oral composition |
US5204089A (en) * | 1989-08-30 | 1993-04-20 | Mitsui Norin Co., Ltd. | Method of preventing the formation or aggrevation of dental plaque and method for reducing cariogenesis |
US5198220A (en) | 1989-11-17 | 1993-03-30 | The Procter & Gamble Company | Sustained release compositions for treating periodontal disease |
US5464609A (en) | 1990-03-16 | 1995-11-07 | The Procter & Gamble Company | Use of ketorolac for treatment of oral diseases and conditions |
DK0449332T3 (en) * | 1990-03-30 | 1995-12-27 | Suntory Ltd | Glucosyltransferase inhibitors, as well as methods for preventing dental caries and anticarious foods containing the same |
JPH0489428A (en) | 1990-07-30 | 1992-03-23 | Kao Corp | Polymorphonuclear leukocyte activator |
US5147632A (en) * | 1990-10-31 | 1992-09-15 | Warner-Lambert Company | Anti-plaque compositions comprising a combination of morpholinoamino alcohol and chelating agent |
US5356615A (en) | 1991-01-30 | 1994-10-18 | Colgate Palmolive Company | Antiplaque oral compositions |
GB9110721D0 (en) * | 1991-05-17 | 1991-07-10 | Unilever Plc | Dentifrice compositions |
AU665381B2 (en) | 1992-01-23 | 1996-01-04 | Morinaga Milk Industry Company Limited | Antibacterial agent and treatment of article therewith |
CN1075868A (en) | 1992-03-02 | 1993-09-08 | 池洁 | A kind of health care toothpick |
US5294433A (en) * | 1992-04-15 | 1994-03-15 | The Procter & Gamble Company | Use of H-2 antagonists for treatment of gingivitis |
US5431927A (en) | 1992-06-16 | 1995-07-11 | Colgate-Palmolive Company | Pet food product having oral care properties |
US5830511A (en) | 1992-06-25 | 1998-11-03 | Bioxy Inc. | Therapeutic, production and immunostimulatory uses of biocidal compositions |
US6004587A (en) | 1992-06-25 | 1999-12-21 | Bioxy Inc. | Therapeutic, production and immunostimulatory uses of biocidal compositions |
JP3333584B2 (en) * | 1993-04-19 | 2002-10-15 | 三井農林株式会社 | Composition for enhancing acid resistance of teeth |
JP3464807B2 (en) | 1993-04-27 | 2003-11-10 | サンスター株式会社 | Toothpaste composition |
US5451401A (en) * | 1993-09-29 | 1995-09-19 | The Procter & Gamble Company | Diphosphonic acid esters as tartar control agents |
CN1103776A (en) | 1993-12-17 | 1995-06-21 | 王殿安 | Tooth-paste with hypertension and brain-thrombus-proof medicine |
GB2290233B (en) | 1994-05-21 | 1998-06-17 | Medical Express | Tooth-whitening compositions containing both chlorite and chlorate salts |
CN1109742A (en) | 1994-09-22 | 1995-10-11 | 许我先 | Toothpaste for health of cardio-cerebral blood vessel |
US5578293A (en) | 1994-12-06 | 1996-11-26 | Colgate Palmolive Company | Oral compositions containing stabilized stannous compounds having antiplaque and antitartar efficacy |
US5639746A (en) | 1994-12-29 | 1997-06-17 | The Procter & Gamble Company | Hydroxamic acid-containing inhibitors of matrix metalloproteases |
US5626838A (en) | 1995-03-13 | 1997-05-06 | The Procter & Gamble Company | Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx |
US5672598A (en) | 1995-03-21 | 1997-09-30 | The Procter & Gamble Company | Lactam-containing hydroxamic acids |
TW442287B (en) | 1995-06-13 | 2001-06-23 | American Home Produits Corp | Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac) |
US6025326A (en) * | 1995-07-07 | 2000-02-15 | Intrabiotics Pharmaceuticals, Inc. | Compositions and methods for the prevention and treatment of oral mucositis |
WO1997016159A1 (en) | 1995-10-30 | 1997-05-09 | Warner-Lambert Company | Enhanced anti-inflammatory oral composition containing h2 receptor antagonist and antimicrobial oils |
DE69719834T2 (en) * | 1996-04-24 | 2003-11-20 | Pfizer Inc., New York | Dental materials containing cyclodextrins and phenolic compounds |
CN1221338A (en) * | 1996-06-12 | 1999-06-30 | 普罗克特和甘保尔公司 | Use of H2-antagonists for manufacture of topical composition for treatment of colds |
US5753217A (en) | 1996-08-14 | 1998-05-19 | William C. Christopfel | Method of reducing oral malodor |
US5766622A (en) * | 1996-08-14 | 1998-06-16 | The Procter & Gamble Company | Inhibiting undesirable taste in oral compositions |
DK0927161T3 (en) | 1996-08-28 | 2003-02-17 | Procter & Gamble | Substituted cyclic amine metalloprotease inhibitors |
AU727820B2 (en) | 1996-08-28 | 2000-12-21 | Procter & Gamble Company, The | 1,3-diheterocyclic metalloprotease inhibitors |
KR20000035917A (en) | 1996-08-28 | 2000-06-26 | 데이비드 엠 모이어 | 1,4-heterocyclic metalloprotease inhibitors |
JP3495376B2 (en) | 1996-08-28 | 2004-02-09 | ザ プロクター アンド ギャンブル カンパニー | Spirocyclic metalloprotease inhibitors |
BR9712792A (en) | 1996-08-28 | 1999-12-14 | Procter & Gamble | Bidentate metalloprotease inhibitors. |
EP0925303B1 (en) | 1996-08-28 | 2002-10-23 | The Procter & Gamble Company | Phosphinic acid amides as matrix metalloprotease inhibitors |
CN1228772A (en) | 1996-08-28 | 1999-09-15 | 普罗克特和甘保尔公司 | Heterocyclic metalloprotease inhibitors |
CA2269473A1 (en) | 1996-10-22 | 1998-04-30 | The Procter & Gamble Company | Oral compositions containing stannous gluconate |
AU4915797A (en) | 1996-10-22 | 1998-05-15 | Procter & Gamble Company, The | Oral compositions containing zinc citrate salts |
NZ335780A (en) | 1996-10-23 | 2001-01-26 | Univ New York State Res Found | Compositions to control oral microbial oxidation-reduction (Eh) levels and treat gingivitis-periodontitis |
US5906811A (en) * | 1997-06-27 | 1999-05-25 | Thione International, Inc. | Intra-oral antioxidant preparations |
BR9810841A (en) | 1997-07-31 | 2001-07-10 | Procter & Gamble | Alicyclic metalloprotease inhibitors |
US5875799A (en) | 1997-09-23 | 1999-03-02 | Advanced Medical Instruments, Inc. | Therapeutic dental floss for treating systemic diseases |
US5875798A (en) | 1997-09-23 | 1999-03-02 | Advanced Medical Instruments, Inc. | Therapeutic toothpick for treating oral and systemic diseases |
CN1213534A (en) | 1997-10-06 | 1999-04-14 | 陈创 | Koutishu treatment and health toothpaste series |
JPH11139947A (en) | 1997-11-11 | 1999-05-25 | Sunstar Inc | Composition containing matrix metalloprotease inhibitor and used for oral cavity |
US6228347B1 (en) * | 1997-12-01 | 2001-05-08 | Thione International, Inc. | Antioxidant gel for gingival conditions |
US6350438B1 (en) * | 1998-02-27 | 2002-02-26 | The Procter & Gamble Company | Oral care compositions comprising chlorite and methods |
US6132702A (en) * | 1998-02-27 | 2000-10-17 | The Procter & Gamble Company | Oral care compositions comprising chlorite and methods |
JP3763075B2 (en) * | 1998-04-24 | 2006-04-05 | サンスター株式会社 | Food composition, oral composition and pharmaceutical composition for prevention or treatment of periodontal disease |
US8496914B2 (en) * | 2005-12-13 | 2013-07-30 | Richard Paul Bonfiglio | Antibacterial oral rinse formulation for preventing coronary artery disease |
-
2001
- 2001-06-28 AU AU2001271544A patent/AU2001271544A1/en not_active Abandoned
- 2001-06-28 DE DE60134854T patent/DE60134854D1/en not_active Expired - Lifetime
- 2001-06-28 PE PE2001000646A patent/PE20020102A1/en not_active Application Discontinuation
- 2001-06-28 EP EP01950569A patent/EP1294367B1/en not_active Revoked
- 2001-06-28 CA CA002415065A patent/CA2415065C/en not_active Expired - Fee Related
- 2001-06-28 CN CNA018118607A patent/CN1536989A/en active Pending
- 2001-06-28 AT AT01950569T patent/ATE401065T1/en not_active IP Right Cessation
- 2001-06-28 JP JP2002506718A patent/JP4754155B2/en not_active Expired - Fee Related
- 2001-06-28 ES ES01950569T patent/ES2309076T3/en not_active Expired - Lifetime
- 2001-06-28 MX MXPA03000043A patent/MXPA03000043A/en active IP Right Grant
- 2001-06-28 WO PCT/US2001/020515 patent/WO2002002096A2/en active Application Filing
-
2006
- 2006-04-24 US US11/409,850 patent/US8277782B2/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115024355A (en) * | 2022-06-09 | 2022-09-09 | 宁波大学科学技术学院 | Preparation method of allicin-based fresh-keeping coating for chilled fresh meat by composite carrier coating |
Also Published As
Publication number | Publication date |
---|---|
CA2415065C (en) | 2009-09-15 |
US8277782B2 (en) | 2012-10-02 |
CN1536989A (en) | 2004-10-13 |
CA2415065A1 (en) | 2002-01-10 |
ATE401065T1 (en) | 2008-08-15 |
DE60134854D1 (en) | 2008-08-28 |
WO2002002096A3 (en) | 2002-09-12 |
JP4754155B2 (en) | 2011-08-24 |
EP1294367A2 (en) | 2003-03-26 |
PE20020102A1 (en) | 2002-03-06 |
JP2004501966A (en) | 2004-01-22 |
WO2002002096A2 (en) | 2002-01-10 |
WO2002002096A8 (en) | 2003-11-06 |
MXPA03000043A (en) | 2003-10-15 |
EP1294367B1 (en) | 2008-07-16 |
US20060193790A1 (en) | 2006-08-31 |
ES2309076T3 (en) | 2008-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001271544A1 (en) | Oral compositions comprising host-response modulating agent | |
CA2415068A1 (en) | Oral compositions comprising antimicrobial agents | |
AR035482A1 (en) | USE OF A CYANOQUINOLINE COMPOUND FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO TREAT OR INHIBIT COLONY POLYPS | |
DE50211204D1 (en) | CANNABIS EXTRACTS PHARMACEUTICAL COMPOSITION | |
MX2007006212A (en) | Oral medicament for the modified release of at least one active principle, in multimicrocapsule form. | |
ATE473749T1 (en) | USE OF RHAMNOLIPIDS FOR WOUND HEALING, TREATMENT AND PREVENTION OF GUM DISEASE AND PERIODONTAL REGENERATION | |
BR0209327A (en) | Composition for treatment of drug-induced constipation | |
RS51154B (en) | Pharmaceutical formulations containing low cocentrations of peroxide for treating or preventing vaginal infections | |
DE60020556D1 (en) | ION CHANNEL MODULATING MEDIUM | |
GEP20043231B (en) | Resorcinol Composition | |
AU6846996A (en) | Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and for treating human malignancies | |
WO2001070184A3 (en) | A composition containing monoterpenes for topical oral administration | |
KR20040087380A (en) | Essential oil composition with excellent antibacterial effect on oral bacteria | |
HUP0300576A2 (en) | Divided dose therapies with vascular damaging activity | |
Shetty et al. | Highlights on role of antibiotics in periodontics | |
EP1374873B8 (en) | The use of n-acetyl-d-glucosamine in the manufacture of pharmaceutical useful for supressing side-effect of radiotherapy and chemotherapy | |
ECSP034647A (en) | USE OF FACTOR VII COAGULATION ACTIVITY TO TREAT SERIOUS BLEEDING THROUGH THERAPY | |
MY136719A (en) | Surfactant system for increasing dental tissue antibacterial agent uptake | |
CN1069516C (en) | Areca catechu medicinal toothpaste composition | |
YU75002A (en) | Topical antioxidant vitamin composition for skin care | |
Karthikeyan et al. | Non-Antibacterial Implications of Tetracyclines in the Management of Periodontitis: An Update. J Immunodefic Disor 2: 1 |